# Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

> **NCT06016569** · NA · RECRUITING · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 3200 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Exhaled breath condensate sampling
- **DIAGNOSTIC_TEST:** Blood sampling
- **PROCEDURE:** LDCT
- **DIAGNOSTIC_TEST:** Vital signs
- **DIAGNOSTIC_TEST:** Spirometry

## Key facts

- **NCT ID:** NCT06016569
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12
- **Target enrollment:** 3200 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06016569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06016569, "Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06016569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*